Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2065 (LINC02065) is a human gene that encodes a long intergenic non-coding RNA (lincRNA). The gene does not code for a protein product, and its biological functions remain largely uncharacterized in the literature. Unlike some lincRNAs such as LINC00665, which are implicated in tumorigenesis and are under study as potential biomarkers or therapeutic targets, there is currently no evidence supporting a disease association or a role as a therapeutic target for LINC02065. It is classified as a lincRNA due to its genomic position (not overlapping coding genes) and non-coding annotation.
None reported; not a direct target for drugs
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2065 (LINC02065).